Infusion pump recalled due to malfunctioning touchscreen
The FDA recalled the Symbiq pump touchscreen (Hospira Inc.) on Oct. 29. The screen may not properly respond to user selection, may have a delayed response, or register a value other than the one selected by the user, an FDA press release said.
Recent Videos
Related Content
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Podcast
Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
